Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) in MONALEESA-2

被引：1

作者：

Sonke, G. S. ^{[1
,2
]}

Hart, L. L. ^{[3
]}

Campone, M. ^{[4
]}

Erdkamp, F. ^{[5
]}

Janni, W. ^{[6
]}

Verma, S. ^{[7
]}

Villanueva, C. ^{[8
]}

Jakobsen, E. ^{[9
]}

Alba, E. ^{[10
]}

Wist, E. ^{[11
]}

Favret, A. M. ^{[12
]}

Bachelot, T. ^{[13
]}

Hegg, R. ^{[14
]}

Wheatley-Price, P. ^{[15
]}

Souami, F. ^{[16
]}

Sutradhar, S. ^{[17
]}

Miller, M. ^{[18
]}

Germa, C. ^{[18
]}

Burris, H. A. ^{[19
]}

机构：

[1] Netherlands Canc Inst, Amsterdam, Netherlands

[2] BOOG Study Ctr, Med Oncol, Amsterdam, Netherlands

[3] Sarah Cannon Res Inst, Florida Canc Specialists & Res Inst, Hematol Oncol, Ft Myers, FL USA

[4] Rene Gauducheau Ctr Rech Cancerol, Inst Cancerol Ouest, Med Oncol, Nantes, France

[5] Zuyderland Med Ctr, Internal Med, Sittard Geleen Heerlen, Netherlands

[6] Univ Klinikum Ulm, Obstet & Gynecol, Ulm, Germany

[7] Tom Baker Canc Clin, Oncol, Calgary, AB, Canada

[8] Hosp Jean Minjoz, Univ Hosp Besancon, Med Oncol, Besancon, France

[9] Lillebaelt Hosp, Clin Oncol, Vejle, Denmark

[10] Hosp Univ Virgen de la Victoria IBIMA, Med Oncol, Malaga, Spain

[11] Oslo Univ Hosp, Oncol, Oslo, Norway

[12] Virginia Canc Specialists PC, Med Oncol, Arlington, VA USA

[13] Ctr Leon Berard, Med Oncol, Lyon, France

[14] Hosp Perola Byington, Ctr Referencia Saude Mulher, Gynecol & Obstet, Sao Paulo, Brazil

[15] Univ Ottawa, Med Oncol, Ottawa, ON, Canada

[16] Novartis Pharma AG, Basel, Switzerland

[17] Novartis Pharma SAS, Paris, France

[18] Novartis Pharmaceut, E Hanover, NJ USA

[19] Sarah Cannon Res Inst, Clin Operat, Nashville, TN USA

来源：

EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷

关键词：

D O I：

10.1016/S0959-8049(17)30091-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2LBA

引用

页码：S1 / S2

页数：3